Abiomed (ABMD) Says Study Demonstrates Early Use of Impella Can Increase Survival in Cardiogenic Shock

September 27, 2019 8:08 AM

Data presented today from the National Cardiogenic Shock Initiative Study (NCSI) on 250 consecutive AMI cardiogenic shock (AMICS) patients from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found